causal

Industry Redundancy Duplicates Trial Capacity

Externalization has trade-offs and creates redundancy, because biotechs preparing to launch must build up duplicate capacity to run trials efficiently, even though the trend has some benefits.

causalpending

Speaker

Alex

Evidence Quote

“people having to build up redundant capacity to run and execute trials in an efficient way.”

Source

Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]— Invest Like the Best
Created: 11/14/2026, 6:42:06 AM

Your notes

Loading notes...